Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neonatal conjunctivitis caused by Chlamydia trachomatis.

I Sandström

    Acta Oto-Laryngologica. Supplementum
    |January 1, 1984
    PubMed
    Summary

    Neonatal Chlamydia trachomatis infections, causing conjunctivitis and pneumonia, require systemic treatment. Oral erythromycin is recommended for infants, with parental treatment also advised to prevent reinfection.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Neonatal chlamydial conjunctivitis. A long term follow-up study.

    Acta paediatrica Scandinavica·1988
    Same author

    [Herpes simplex virus infections--etiology and diagnosis].

    Lakartidningen·1988
    Same author

    Levels of erythromycin in tear fluid and serum in infants with conjunctivitis.

    Scandinavian journal of infectious diseases·1988
    Same author

    Treatment of neonatal conjunctivitis.

    Archives of ophthalmology (Chicago, Ill. : 1960)·1987
    Same author

    Etiology and diagnosis of neonatal conjunctivitis.

    Acta paediatrica Scandinavica·1987
    Same author

    Ophthalmia neonatorum with special reference to Chlamydia trachomatis. Diagnosis and treatment.

    Acta paediatrica Scandinavica. Supplement·1986

    Area of Science:

    • Neonatal infections
    • Ophthalmology
    • Pediatric infectious diseases

    Background:

    • Chlamydia trachomatis is a frequent cause of neonatal infections in industrialized nations.
    • Infection is acquired from the maternal cervix, leading to colonization of mucosal surfaces like the conjunctiva, respiratory, and gastrointestinal tracts.
    • Recognized manifestations include conjunctivitis and pneumonia, with C. trachomatis found in 14-25% of neonatal conjunctivitis cases.

    Purpose of the Study:

    • To outline the clinical manifestations and recommended treatment for Chlamydia trachomatis infections in neonates.
    • To emphasize the importance of systemic therapy due to the potential for systemic spread.
    • To provide guidance on appropriate antibiotic regimens for affected infants and their parents.

    Main Methods:

    • Review of clinical presentations and etiological agents of neonatal infections.
    • Analysis of diagnostic findings for Chlamydia trachomatis in neonatal conjunctivitis and associated infections.
    • Evaluation of established treatment protocols for neonatal chlamydial infections.

    Main Results:

    • Neonatal conjunctivitis, often the initial sign, can indicate systemic C. trachomatis infection.
    • Oral erythromycin (25 mg/kg every 12 hours for 14 days) is the established treatment for neonatal chlamydial conjunctivitis.
    • The recommended dosage of erythromycin is well-tolerated by infants.

    Conclusions:

    • Systemic therapy is crucial for neonatal Chlamydia trachomatis infections.
    • Oral erythromycin is an effective and safe treatment for neonatal chlamydial conjunctivitis.
    • Maternal and paternal treatment with oral erythromycin or tetracyclines is essential to prevent infant reinfection and transmission.

    Related Experiment Videos